3rd Annual CEE Pharmaceutical Challenges
Last Updated on Tuesday, 25 April 2006 04:30 Written by admin Tuesday, 25 April 2006 04:30
Date: 12th & 13th June 2006, Budapest
Â
Event Summary:
This event will provide a platform for discussing the hottest issues in the region today. Representatives of the leading pharmaceutical companies, regulatory bodies and associations will explore how to overcome the challenges of successful cooperation with the local governments, parallel trade, EU regulations and the role of generics in the CEE region.
This five star event is the ideal meeting place for leaders, who wish to get first hand information on the industry, network with their industry peers and get to know their competitors.
Â
Luiz Gonzalez Vaque, Adviser, European Commission
Krisztina Szekely, Head of Corporate Affairs / President of the Association of Innovative Pharmaceutical Manufacturers (AIPM), Pfizer Hungary
Oliver Schwerdt, Global Pricing Manager, Schering AG
Laura de la Iglesia Gutierrez, European Public Affairs Manager, Novartis International
Radunka Cvejic, External Affairs Director, AstraZeneca Poland
The impact of EU enlargement on the Parallel Trade; find out whether it is a threat or a benefit
Identifying sustainable Pharma pricing strategies and utilizing them to practical needs; Pricing and Reimbursement workflows in practice – Schering case study
Cooperation with the Government – what are the best ways to promote interests of pharmaceutical companies
Role of Generics in CEE region – learn how to build a relationship between original and generics Pharma companies in CEE
Emerging Market Overviews – find out all the details from people that work in markets of Romania, Ukraine and Croatia
Country Managers, Area Directors, Directors and Senior Managers from areas of Business Development, Strategic Planning, Governmental Affairs, Corporate Affairs, Pricing & Reimbursement
Advanced Info (url):
http://www.jacobfleming.com/buxus/generate_page.php?page_id=230
Main Menu
- Home
- About Bioscreening.net
- Glossary
- Biotechnology Glossary A-I
- Biotechnology Glossary J-Q
- Biotechnology Glossary R-Z
- Bird Flu
- Cheminformatic Glossary
- Endotoxins
- Fullerenes
- Genipin
- Gossypol (Gossipol)
- Grants, Venture Capital, and Government Funding
- High-throughput screening
- Lipinski Rule-of-Five
- Mumie
- Natural Medicine
- Rule-of-Three (Ro3)
- Targeted Libraries
- Web Directory